Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Jacquelyn Martin / AP

Those massive health insurance mergers may be dead, but the lawyers and investment bankers who worked feverishly to get the deals approved still walked away with big paychecks.

Aetna, Anthem, Cigna and Humana cumulatively spent about $1.5 billion on legal and financial fees since their proposed mergers were announced in summer 2015, according to documents filed with the Securities and Exchange Commission. That price tag covers the fights over Aetna's $37 billion merger attempt with Humana and Anthem's $53 billion bid for Cigna, both of which were slapped down by the courts. Read on to see where the money went.

The $1.5 billion has been funneled to banks like Goldman Sachs, Citigroup and Credit Suisse and law firm giants like White & Case and Jones Day, which battled the Justice Department in court. That sum would have been enough to pay for the average Obamacare plan for more than 300,000 people for all of 2017, based on data from HealthPocket.

The insurance companies also hired consulting firms like Compass Lexecon. A recent ProPublica report profiled that firm, which provides highly paid academics who argue in favor of large mergers in court.

Why it matters: The big spending creates problems for consumers and investors. Consumers are paying for it through their insurance premiums, which continue to rise faster than general inflation.

And every dollar spent on legal teams and financiers is a dollar investors lose. In 2016, Anthem said the expenses associated with its takeover of Cigna cost its shareholders $1.20 in earnings per share, while Aetna said its transaction with Humana sucked away $1.46 in earnings per share.

Here's how the money breaks down, according to the SEC filings. All figures represent pre-tax expenses:

  • Aetna: $775 million. Most (about $517 million) was spent in 2016. Not all the money is tied to the Humana acquisition, but a vast "majority" is, according to an Aetna spokesman — meaning the spending was at least $400 million and likely almost all of the total.
  • Humana: $127 million. More than 80% of that total ($104 million) was spent in 2016.
  • Anthem: $424.1 million. This will only increase since Anthem said it will appeal its decision.
  • Cigna: $232 million. About $166 million was spent in 2016.
Expand chart

Data: SEC; Chart: Lazaro Gamio / Axios

The judges made it clear that the deals flouted antitrust law. One argument that did not win over critics was that the combined companies would have saved money for people through lower premiums, partially by trimming some administrative fat. The judge in the Anthem-Cigna case was especially skeptical of that claim. The merger costs, meanwhile, have been booked as general and administrative expenses.

This is not a frivolous amount of money. Aetna's merger costs in 2016, for example, represented 5% of its entire administrative budget. But the costs still only totaled 1.2% of what Aetna paid out in health care claims in the same time frame — roughly $44.3 billion.

Go deeper

House passes $1.9 trillion COVID relief package

Photo: Screenshot via C-SPAN

The House approved President Biden's $1.9 trillion COVID relief package on a 219-212 vote early Saturday morning, sending it to the Senate for a possible rewrite before it gets to Biden's desk.

The big picture: The vote was a critical first step for the package, which includes $1,400 cash payments for many Americans, a national vaccination program, ramped-up COVID testing and contact tracing, state and local funding and money to help schools reopen.

10 hours ago - Health

Biden says it's "not the time to relax" after touring vaccination site

President Biden speaking after visiting a FEMA Covid-19 vaccination facility in Houston on Feb. 26. Photo: Mandel Ngan/AFP via Getty Images

President Biden said Friday that "it's not the time to relax" coronavirus mitigation efforts and warned that the number of cases and hospitalizations could rise again as new variants of the virus emerge.

Why it matters: Biden, who made the remarks after touring a vaccination site in Houston, echoed CDC director Rochelle Walensky, who said earlier on Friday that while the U.S. has seen a recent drop in cases and hospitalizations, "these declines follow the highest peak we have experienced in the pandemic."

Updated 10 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Health: Most COVID-19 survivors can weather risk of reinfection, study says — "Twindemic" averted as flu reports plummet amid coronavirus crisis
  2. Vaccine: FDA advisory panel endorses J&J COVID vaccine for emergency use — About 20% of U.S. adults have received first vaccine dose, White House says — New data reignites the debate over coronavirus vaccine strategy.
  3. Economy: What's really going on with the labor market.
  4. Local: All adult Minnesotans will likely be eligible for COVID-19 vaccine by summer — Another wealthy Florida community receives special access to COVID-19 vaccine.
  5. Sports: Poll weighs impact of athlete vaccination.